Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
Main Authors: | Hongjie Chen, Jiepeng Chen, Fuping Zhang, Yuanhui Li, Ronghua Wang, Qiang Zheng, Xu Zhang, Jun Zeng, Feng Xu, Yiguang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1076420/full |
Similar Items
-
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
by: Hongjie Chen, et al.
Published: (2022-08-01) -
Effects of Nattokinase on Whole Blood Viscosity and Mortality
by: Melike Cengiz, et al.
Published: (2011-12-01) -
Research Progress on Functional Vectors for Nattokinase Delivery
by: XIE Minghao, XU Xianbing, WANG Zhenyu, CHENG Shuzhen, DU Ming
Published: (2023-09-01) -
Nattokinase: A hope in cardiovascular therapy and more
by: Dan-Dominic IONESCU
Published: (2020-09-01) -
The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Xiaoming Liu, et al.
Published: (2023-09-01)